Literature DB >> 29490146

MiR-378 promotes the cell proliferation of osteosarcoma through down-regulating the expression of Kruppel-like factor 9.

Ningning Peng1,1, Zhigang Miao1,1, Liguo Wang1,1, Binbin Liu1,1, Guijiang Wang1,1, Xu Guo1,1.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that play important roles in a variety of biological processes. Dysregulation of miRNAs is tightly associated with the malignancy of cancers. Aberrant expression of miR-378 has been observed in human cancers; however, the function of miR-378 in osteosarcoma (OS) remains largely unknown. Here, we showed that miR-378 was highly expressed in human OS tissues and cell lines. Overexpression of miR-378 significantly promoted the cell proliferation of OS cells. Molecular studies identified Kruppel-like factor-9 (KLF9) as a functional downstream target of miR-378. MiR-378 directly bound to the mRNA 3'-UTR region of KLF9 and suppressed the expression of KLF9. Highly expressed KLF9 reversed the promoting effect of miR-378 on the proliferation of OS cells. The expression level of miR-378 was negatively correlated with that of KLF9 in OS tissues. Collectively, our results demonstrated the molecular interaction between miR-378 and KLF9, indicating the therapeutic potential of miR-378 for OS.

Entities:  

Keywords:  KLF9; cell proliferation; expression génique; gene expression; miR-378; osteosarcoma; ostéosarcome; prolifération cellulaire

Mesh:

Substances:

Year:  2018        PMID: 29490146     DOI: 10.1139/bcb-2017-0186

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  7 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Elevated levels of both microRNA 378 (miR-378) and kallikrein-related peptidase 4 (KLK4) mRNA are associated with an unfavorable prognosis in triple-negative breast cancer.

Authors:  Weiwei Gong; Caixia Zhu; Yueyang Liu; Alexander Muckenhuber; Holger Bronger; Andreas Scorilas; Marion Kiechle; Julia Dorn; Viktor Magdolen; Tobias Dreyer
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

3.  microRNA-378a-5p iS a novel positive regulator of melanoma progression.

Authors:  Maria Grazia Tupone; Simona D'Aguanno; Marta Di Martile; Elisabetta Valentini; Marianna Desideri; Daniela Trisciuoglio; Sara Donzelli; Andrea Sacconi; Simonetta Buglioni; Cristiana Ercolani; Alessio Biagioni; Gabriella Fibbi; Luigi Fattore; Rita Mancini; Gennaro Ciliberto; Giovanni Blandino; Donatella Del Bufalo
Journal:  Oncogenesis       Date:  2020-02-14       Impact factor: 7.485

4.  Let-7a inhibits osteosarcoma cell growth and lung metastasis by targeting Aurora-B.

Authors:  Jing-Jing Yu; Wen-Sen Pi; Yuan Cao; Ai-Fen Peng; Zhi-Yuan Cao; Jia-Ming Liu; Shan-Hu Huang; Zhi-Li Liu; Wei Zhang
Journal:  Cancer Manag Res       Date:  2018-11-26       Impact factor: 3.989

5.  Circular RNA_0078767 upregulates Kruppel-like factor 9 expression by targeting microRNA-889, thereby inhibiting the progression of osteosarcoma.

Authors:  Qiu Chen; Haishen Zhou; Weihao Rong
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

6.  Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.

Authors:  Yan Zhang; Hongjie Xu
Journal:  J Clin Lab Anal       Date:  2020-02-14       Impact factor: 2.352

7.  CircNFIX promotes progression of glioma through regulating miR-378e/RPN2 axis.

Authors:  Chenyu Ding; Zanyi Wu; Honghai You; Hongliang Ge; Shufa Zheng; Yuanxiang Lin; Xiyue Wu; Zhangya Lin; Dezhi Kang
Journal:  J Exp Clin Cancer Res       Date:  2019-12-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.